Immunoproteomics: From biomarker discovery to diagnostic applications

Proteomics - Clinical Applications

Volumn 2, Issue 2, 2008, Pages 167-180

  Tjalsma, Harold ^a   Schaeps, Renée M J ^a   Swinkels, Dorine W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

2 D PAGE; Antigens; Cancer; Diagnostics; Immune response; LC MS MS

Indexed keywords

ANTIBODY; ANTIGEN; BIOLOGICAL MARKER; COMPLEMENTARY DNA; EPITHELIAL CELL ADHESION MOLECULE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PLASMA PROTEIN; SMALLPOX VACCINE;

ANTIBODY BLOOD LEVEL; ANTIGEN DETECTION; AUTOIMMUNE DISEASE; BIOTECHNOLOGY; CELLULAR IMMUNITY; COLON CANCER; DIAGNOSTIC VALUE; DNA MICROARRAY; DRUG MONITORING; DRUG SCREENING; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL; HEMATOLOGIC MALIGNANCY; HIGH THROUGHPUT SCREENING; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; INFECTION; MALIGNANT NEOPLASTIC DISEASE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEOMICS; REVIEW; STOMACH CANCER; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 39649097837     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780012     Document Type: Review

References (91)

1. Jungblut, P. R., Proteome analysis of bacterial pathogens. Microbes Infect. 2001, 3, 831-840.
2. Alberts, B., Johnson, A., Lewis, J., Raff, M. et al., Molecular Biology of the Cell, 4th Edn., Garland Science, New York and London 2002.
3. Litman, G., Cannon, J., Dishaw, L., Reconstructing immune phylogeny: New perspectives. Nat. Rev. Immunol. 2005, 5, 866-879.
4. Purcell, A. W., Gorman, J. J., Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune response. Mol. Cell. Proteomics 2004, 3, 193-208.
5. Sproul, T., Cheng, P., Dykstra, M., Pierce, S., A role for MHC class II antigen processing in B cell development. Int. Rev. Immunol. 2000, 19, 139-55.
6. Kehry, M., Hodgkin, P., B-cell activation by helper T-cell membranes. Crit. Rev. Immunol. 1994, 14, 221-238.
7. Naour, F. L., Brichory, F., Beretta, L., Hanash, S. M., Identification of tumor-associated antigens using proteomics. Technol. Cancer Res. Treat. 2002, 1, 257-262.
8. Hess, J. L., Blazer, L., Romer, T., Faber, L. et al., Immunoproteomics. J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci. 2005, 815, 65-75.
9. Anderson, K. S., LaBaer, J., The sentinel within: Exploiting the immune system for cancer biomarkers. J. Proteome Res. 2005, 4, 1123-1133.
10. Hortin, G. L., Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice? Clin. Chem. 2005, 51, 3-5.
11. Master, S. R., Diagnostic proteomics: Back to basics? Clin. Chem. 2005, 51, 1333-1334.
12. O'Farrell, P. H, High-resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 1975, 250, 4007-4021.
13. Klade, C. S., Voss, T., Krystek, E., Ahorn, H. et al., Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics 2001, 1, 890-898.
14. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
15. Gloerich, J., Wevers, R. A., Smeitink, J. A., van Engelen, B. G., van den Heuvel, L. P., Proteomics approaches to study genetic and metabolic disorders. J. Proteome. Res. 2007, 6, 506-512.
16. Lopez, J. L., Two-dimensional electrophoresis in proteome expression analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci. 2007, 849, 190-202.
17. Towbin, H., Staehelin, T., Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA 1979, 76, 4350-4354.
18. Mortz, E., Vorm, O., Mann, M., Roepstorff, P., Identification of proteins in polyacrylamide gels by mass spectrometric peptide mapping combined with database search. Biol. Mass Spectrom. 1994, 23, 249-261.
19. Nesvizhskii, A. I., Protein identification by tandem mass epectrometry and sequence database searching. Methods Mol. Biol. 2007, 367, 87-119.
20. Nakanishi, T., Ando, E., Furuta, M., Tsunasawa, S., Nishimura, O., Direct on-membrane peptide mass fingerprinting with MALDI-MS of tyrosine-phosphorylated proteins detected by immunostaining. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 847, 24-29.
21. Falisse-Poirrier, N., Ruelle, V., ElMoualij, B., Zorzi, D. et al., Advances in immunoproteomics for serological characterization of microbial antigens. J. Microbiol. Methods 2006, 67, 593-596.
22. Robinson, W. H., Antigen arrays for antibody profiling. Curr. Opin. Chem. Biol. 2006, 10, 67-72.
23. Hueber, W., Robinson, W. H., Proteomic biomarkers for autoimmune disease. Proteomics 2006, 6, 4100-4106.
24. Robinson, M. H., DiGennaro, C., Hueber, W., Haab, B. B. et al., Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 2002, 8, 295-301.
25. Haab, B. B., Dunham, M. J., Brown, P. O., Protein micro-arrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2001, 2, research0004.
26. Qiu, J., Madoz-Gurpide, J., Misek, D. E., Kuick, R., Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. J. Proteome Res, 2004, 3, 261-267.
27. Bertone, P., Snyder, M., Advances in functional protein microarray technology. FEBS J. 2006, 272, 5400-5411.
28. Caiazzo, R. J., Tassinari, O. W., Ehrlich, J. R., Liu, B. C., Autoantibody microarrays for biomarker discovery. Expert Rev. Proteomics 2007, 4, 261-272.
29. Cekaite, L., Hovig, E., Sioud, M., Protein arrays: A versatile toolbox for target identification and monitoring of patient immune responses. Methods Mol. Biol. 2007, 360, 335-348.
30. Gunawardana, C. G., Diamandis, E. P., High throughput proteomic strategies for identifying tumour-associated antigens. Cancer Lett. 2007, 249, 110-119.
31. Grus, F. H., Joachim, S. C., Pfeiffer, N., Analysis of complex autoantibody repertoires by surface-enhanced laser desorption/ ionization-time of flight mass spectrometry. Proteomics 2003, 3, 957-961.
32. Tjalsma, H., Schöller-Guinard, M., Lasonder, E., Ruers, T. J. et al., Profiling the humoral immune response in colon cancer patients: Diagnostic antigens from Streptococcus bovis. Int. J. Cancer 2006, 119, 2127-2135.
33. Pan, C., Xu, S., Zhou, H., Fu, Y. et al., Recent developments in methods and technology for analysis of biological samples by MALDI-TOF-MS. Anal. Bioanal. Chem. 2007, 387, 193-204.
34. Villar-Garea, A., Griese, M., Imhof, A. Biomarker discovery from body fluids using mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 15, 105-114.
35. Tjalsma, H., Lasonder, E., Schöller-Guinard, M., Swinkels, D. W., Shotgun immunoproteomics to identify disease-associated bacterial antigens: Application to human colon cancer. Proteomics Clin. Appl. 2007, 1, 429-434.
36. Philip, R., Murthy, S., Krakover, J., Sinnathamby, G. et al., Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: Potential theranostic approach to cancer. J. Proteome Res. 2007, 6, 2509-2517.
37. Haab, B. B., Applications of antibody array platforms. Curr. Opin. Biotechnol. 2006, 17, 416-421.
38. Gershoni, J. M., Roitburd-Berman, A., Siman-Tov, D. D., Tarnovitski Freund, N., Weiss, Y., Epitope mapping: The first step in developing epitope-based vaccines. BioDrugs 2007, 21, 145-156.
39. Benjamin, D. C., B-cell epitopes: Fact and fiction. Adv. Exp. Med. Biol. 1995, 386, 95-108.
40. Huang, J., Honda, W., CED: A conformational epitope database. BMC Immunol. 2006, 7, 7.
41. Villalta, D., Tozzoli, R., Tonutti, E., Bizzaro, N., The laboratory approach to the diagnosis of autoimmune diseases: Is it time to change? Autoimmun. Rev. 2007, 6, 359-365.
42. Voller, A., Bartlett, A., Bidwell, D. E., Enzyme immunoassays with special reference to ELISA techniques. J. Clin. Pathol. 1978, 31, 507-520.
43. Harrop, R., Ryan, M. G., Golding, H., Redchenko, I., Carroll, M. W., Monitoring of human immunological responses to vaccinia virus. Methods Mol. Biol. 2004, 269, 243-266.
44. Rabenau, H. F., Marianov, B., Wicker, S., Allwinn, R., Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparations. Med. Microbiol. Immunol. 2007, 196, 151-155.
45. Davies, D. H., Liang, X., Hernandez, J. E., Randall, A. et al., Profiling the humoral immune response to infection by using proteome microarrays: High-throughput vaccine and diagnostic antigen discovery. Proc. Natl. Acad. Sci. USA 2005, 102, 547-552.
46. Bacarese-Hamilton, T., Ardizzoni, A., Gray, J., Crisanti, A., Protein arrays for serodiagnosis of disease. Methods Mol. Biol. 2004, 264, 271-83.
47. Nielsen, U. B., Geierstanger, B. H., Multiplexed sandwich assays in microarray format. J. Immunol. Methods 2004, 290, 107-120.
48. Ling, M. M., Ricks, C., Lea, P., Multiplexing molecular diagnostics and immunoassays using emerging microarray technologies. Expert Rev. Mol. Diagn. 2007, 7, 87-98.
49. Vignali, D. A., Multiplexed particle-based flow cytometric assays. J. Immunol. Methods 2000, 243, 243-255.
50. Whiteaker, J, R., Zhao, L., Zhang, H. Y., Feng, L. C., Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal. Biochem. 2007, 362, 44-54.
51. Ketterlinus, R., Hsieh, S. Y., Teng, S. H., Lee, H., Pusch, W., Fishing for biomarkers: Analyzing mass spectrometry data with the new ClinProTools software. Biotechniques 2005, Suppl, 37-40.
52. Poon, T. C., Opportunities and limitations of SELDI-TOF-MS in biomedical research: Practical advices. Expert. Rev. Proteomics 2007, 4, 51-65.
53. Kemna, E. H., Tjalsma, H., Laarakkers, C., Nemeth, E. et al., Novel urine hepcidin assay by mass spectrometry. Blood 2005, 106, 3268-3270.
54. Kemna, E. H., Tjalsma, H., Podust, V. N., Swinkels, D. W., Mass spectrometry-based hepcidin measurements in serum and urine: Analytical aspects and clinical implications. Clin. Chem. 2007, 53, 620-628.
55. Baggerly, K. A., Morris, J. S., Coombes, K. R., Reproducibility of SELDI-TOF protein patterns in serum: Comparing datasets from different experiments. Bioinformatics 2004, 20, 777-785.
56. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J. et al., Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359, 572-677.
57. Chen, Z., Peng, B., Wang, S., Peng, X., Rapid screening of highly efficient vaccine candidates by immunoproteomics. Proteomics 2004, 4, 3203-3213.
58. Davies, D. H., Molina, D. M., Wrammert, J., Miller, J. et al., Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics 2007, 7, 1678-1686.
59. Dürauer, A., Berger, E., Schuster, M., Wasserbauer, E. et al., Peptide arrays for the determination of humoral responses induced by active immunization with a monoclonal antibody against EpCAM. Immunol. Methods. 2006, 317, 114-125.
60. Ryan, M. H., Heavner, G. A., Brigham-Burke, M., McMahon, F. et al., An in vivo model to assess factors that may stimulate the generation of an immune reaction to erythropoietin. Int. Immunopharmacol. 2006, 6, 647-665.
61. De Groot, A. S., Moise, L., Prediction of immunogenicity for therapeutic proteins: State of the art. Curr. Opin. Drug. Discov. Devel. 2007, 10, 332-340.
62. Hueber, W., Kidd, B. A., Tomooka, B. H., Lee, B. J., Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum. 2005, 52, 2645-2665.
63. Balboni, I., Chan, S. M., Kattah, M., Tenenbaum, J. D. et al., Multiplexed protein array platforms for analysis of autoimmune diseases. Annu. Rev. Immunol. 2006, 24, 391-418.
64. Avent, N. D., Madgett, T. E., Lee, Z. E., Head, D, J. et al., Molecular biology of Rh proteins and relevance to molecular medicine. Expert. Rev. Mol. Med. 2006, 8, 1-20.
65. Sargent, I. L., Germain, S. J., Sacks, G. P., Kumar, S., Redman, C. W. Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J. Reprod. Immunol. 2003, 59, 153-160.
66. Harwanegg, C., Hiller, R., Protein microarrays for the diagnosis of allergic diseases: State-of-the-art and future development. Allerg. Immunol. 2006, 38, 232-236.
67. Li, Q. Z., Xie, C., Wu, T., Mackay, M. et al., Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J. Clin. Invest. 2005, 115, 3428-3439.
68. Hueber, W., Kidd, B. A., Tomooka, B. H., Lee, B. J. et al., Proteomic analysis of autoantibody reactivities provides diagnostic information and allows stratification of patients with early RA into clinically relevant disease subsets. Arthritis Rheum. 2005, 52, 2645-2655.
69. Hueber, W., Tomooka, B. H., Zhao, X., Kidd, B. A. et al., Proteomic analysis of secreted proteins in early rheumatoid arthritis: Anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Ann. Rheum. Dis. 2007, 66, 712-719.
70. Chen, Y. T., Scanlan, M. J., Sahin, U., Tureci, O. et al., A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA 1997, 94, 1914-1918.
71. Soussi, T., p53 antibodies in the sera of patients with various types of cancer: A review. Cancer Res. 2000, 60, 1777-1788.
72. Hermsen, B. B., Verheijen, R. H., Menko, F. H., Gille, J. J. et al., Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation. Eur. J. Cancer 2007, 43, 1556-1563.
73. Caron, M., Choquet-Kastylevsky, G., Joubert-Caron, R., Cancer immunomics using autoantibody signatures for biomarker discovery. Mol. Cell. Proteomics 2007, 6, 1115-1122.
74. Kesari, K. V., Yoshizaki, N., Geng, X., Lin, J. J., Das, K. M. Externalization of tropomyosin isoform 5 in colon epithelial cells. Clin. Exp. Immunol. 1999, 118, 219-227.
75. Shi, F. D., Zhang, J. Y., Liu, D., Rearden, A. et al., Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens. Prostate 2005, 63, 252-258.
76. Trivers, G. E., Cawley, H. L., DeBenedetti, V. M., Hollstein, M. et al., Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride. J. Natl. Cancer Inst. 1995, 87, 1400-1407.
77. Cawley, H. M., Meltzer, S. J., De Benedetti, V. M., Hollstein, M. C. et al., Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis. Gastroenterology 1998, 115, 19-27.
78. Zeng, G., Aldridge, M. E., Wang, Y., Pantuck, A. J. et al., Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: Implications as a potential biomarker. Int. J. Cancer 2005, 114, 268-273.
79. Coleman, S. A., Fischer, E. R., Cockrell, D. C., Voth, D. E. et al., Proteome and antigen profiling of Coxiella burnetii developmental forms. Infect. Immun. 2007, 75, 290-298.
80. Forgber, M., Basu, R., Roychoudhury, K., Theinert, S. et al., Mapping the antigenicity of the parasites in leishmania donovani Infection by proteome serology. PLoS ONE 2006, 20, e40.
81. Nowalk, A. J., Gilmore, R. D., Carroll, J. A., Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins. Infect. Immun. 2006, 74, 3864-3873.
82. Hellstrom, P. M., This year's Nobel Prize to gastroenterology: Robin Warren and Barry Marshall awarded for their discovery of Helicobacter pylori as pathogen in the gastro-intestinal tract. World J. Gastroenterol. 2006, 12, 3126-3127.
83. Utt, M., Nilsson, I., Ljungh, A., Wadström, T., Identification of novel immunogenic proteins of Helicobacter pylori by proteome technology. J. Immunol. Methods. 2002, 259, 1-10.
84. Jungblut, P. R., Bumann, D., Immunoproteome of Helicobacter pylori. Methods Enzymol. 2002, 358, 307-316.
85. Lin, Y. F., Chen, C. Y., Tsai, M. H., Wu, M. S. et al., Duodenal ulcer-related antigens from Helicobacter pylori: immunoproteome and protein microarray approaches. Mol. Cell. Proteomics 2007, 6, 1018-1026.
86. Pitarch, A., Abian, J., Carrascal, M., Sánchez, M. et al., Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies. Proteomics 2004, 4, 3084-3106.
87. Klein, R. S., Recco, R. A., Catalano, M. T., Edberg, S. C. et al., Association of Streptococcus bovis with carcinoma of the colon. N. Engl. J. Med. 1977, 297, 800-802.
88. Haimowitz, M. D., Hernandez, L. A., Herron, R. M., Jr., A blood donor with bacteraemia. Lancet 2005, 365, 1596.
89. Etzioni, R., Urban, N., Ramsey, S., Mcintosh, M. et al., The case for early detection. Nat. Rev. Cancer 2003, 3, 243-252.
90. zur Hausen, H., Streptococcus bovis: Causal or incidental involvement in cancer of the colon? Int. J. Cancer 2006, 119, xi-xii.
91. Albrethsen, J., Reproducibility in protein profiling by MALDI-TOF mass spectrometry. Clin. Chem. 2007, 53, 852-858.